The meeting „Tumor Immunology meets Oncology (TIMO)“ has established itself as an outstanding platform for exchange between scientists, clinicians and junior staff and as one of the leading European conferences in the field of tumor immunology. From 14-16 May 2020, it will take place for the 16th time at the Martin Luther University Halle-Wittenberg in the lecture hall of the University Hospital Kröllwitz, Halle (Saale). With an increasing number of participants and a positive echo throughout, we are able to win not only highly recognized national but also international speakers – just to name a few keynote speakers of the past years: Shuji Ogino (Dana-Farber Cancer Institute Boston, 2019), Thomas Gajewski (University of Chicago, 2018), Alberto Mantovani (Instituto Clinico Humanitas Milan, 2017), Olivera J. Finn (University of Pittsburgh, 2016), Nicholas McGranahan (The Francis Crick Institute London, 2015).
Arbeitskreise
Meeting of the AK Tumor Immunology Arbeitskreise
For our 2020 meeting we have already received commitments from, among others, Sylvia Adams (NYU Langone Laura and Isaac Perlmutter Cancer Center), Edgardo D. Carosella (Hopital Saint-Louis Paris), Julian Downward (The Francis Crick Institute, London), Gal Markel (Tel Aviv University), Douglas McNeel (University of Wisconsin – Madison) and Theresa L. Whiteside (University of Pittsburgh Cancer Institute).
The symposium takes place over three days and begins with a workshop that enables young scientists to present their own data in a short lecture. The latest methods and techniques in the field of tumor treatment will also be presented. The accompanying poster exhibition facilitates discussion of further projects and the establishment of new cooperations. Following the workshop, we will award prizes for the three best lectures and posters. The scientific program will be rounded off with a networking evening allowing the discussion of projects and experiments in a relaxed atmosphere.
If you would like to have the chance to be selected for an oral presentation or poster please register by April 1, 2020.
Preliminary programm 2020
This programm is preliminary, changes are possible.
If you cannot see the PDF, please re-load the page or download here.
On the following two days, the established and renowned scientists will have their say. In 2019, the topics covered by the speakers ranged from basic to translational science and clinical phase II and III trials in particular immune escape and resistance mechanisms of tumors, the cellular composition of the tumor infiltrate, tumor mutational burden, anti-tumoral function of NK and T cells and epidemiologic studies up to clinical trials using adoptive cell therapy (ACT), epigenetic drugs as well as immune checkpoint inhibitors (iCPI) alone or in combination.
The meeting is made possible by the great commitment of the members of the Institute of Medical Immunology, the support of the German Society of Immunology (DGfI), the Society of Immunotherapy in Cancer (SITC) and its staff as well as the commitment of numerous sponsors. We are looking forward to another exciting event in 2020!
Conference venue
Martin Luther University, University Hospital (Halle-Kröllwitz), Halle (Saale)
Site map of the university hospital with location of the lecture hall
Our sponsors
Without the support of our sponsors, we would not be able to offer this meeting at prices that also allow young scientists to participate. Thank you very much!
These are the sponsors of our last meeting in 2019. If you are a sponsor and would like to join us for the 2020 meeting, please contact us as soon as possible (Ms Maria Heise, maria.heise@uk-halle.de)
